ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,003Medicare Part D Prescriptions Filled, Including Refills

Rank: 38 out of 1000

$1.26M Total Retail Price of All Prescriptions

Rank: 23 out of 1000

612 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
72% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 612 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

25% of this provider’s 612 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

2% of this provider’s 16,384 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
LEVOTHYROXINE SODIUM 783 541 1 4
OMEPRAZOLE 782 501 2 2
HYDROCODONE-ACETAMINOPHEN 729 386 S3 3 1
SIMVASTATIN 585 426 4 3
LISINOPRIL 545 442 5 5
FUROSEMIDE 517 415 6 7
AMLODIPINE BESYLATE 505 395 7 6
GABAPENTIN 351 243 8 11
POTASSIUM CHLORIDE 318 237 9 10
CITALOPRAM HBR 316 230 10 17
NAMENDA 314 314 11 43
ZOLPIDEM TARTRATE 309 198 12 16
METFORMIN HCL 304 203 13 8
TRAMADOL HCL 295 210 14 13
TRAZODONE HCL 290 213 15 29
HYDROCHLOROTHIAZIDE 289 219 16 9
CLONIDINE HCL 281 201 17 27
CARVEDILOL 271 224 18 15
TRIAMTERENE-HCTZ 261 123 19 48
ALLOPURINOL 232 167 20 31
MIRTAZAPINE 232 193 20 56
LOSARTAN POTASSIUM 231 181 22 25
LISINOPRIL-HYDROCHLOROTHIAZIDE 225 134 23 20
ATENOLOL 213 152 24 24
EXELON 199 199 25 108
PANTOPRAZOLE SODIUM 192 146 26 28
MELOXICAM 174 125 27 14
PRAVASTATIN SODIUM 169 128 28 12
WARFARIN SODIUM 166 145 29 22
METOPROLOL TARTRATE 160 152 30 19
METFORMIN HCL ER 151 60 31 44
DIGOXIN 146 97 32 52
RANITIDINE HCL 146 89 32 37
FLUOXETINE HCL 145 105 34 51
FENOFIBRATE 144 110 35 55
SERTRALINE HCL 143 125 36 26
GLIMEPIRIDE 140 131 37 34
VERAPAMIL ER 135 74 38 86
ATORVASTATIN CALCIUM 128 88 39 18
LANTUS 126 95 40 68
CLOPIDOGREL 118 88 41 35
DIOVAN HCT 115 91 42 96
NEXIUM 115 89 42 23
PAROXETINE HCL 115 96 42 63
LOSARTAN-HYDROCHLOROTHIAZIDE 114 71 45 38
METOPROLOL SUCCINATE 112 81 46 21
CYCLOBENZAPRINE HCL 109 31 R 47 39
TAMSULOSIN HCL 105 71 48 33
ESCITALOPRAM OXALATE 104 66 49 60
KLOR-CON M20 104 83 49 66
ADVAIR DISKUS 103 82 51 65
QUETIAPINE FUMARATE 101 79 52 75
PLAVIX 97 72 53 49
LOVASTATIN 92 65 54 41
NITROGLYCERIN PATCH 89 67 55 226
PREDNISONE 89 65 55 42
PRAMIPEXOLE DIHYDROCHLORIDE 89 79 55 147
MORPHINE SULFATE ER 88 49 S2 58 143
HYDRALAZINE HCL 88 73 58 74
AMIODARONE HCL 87 80 60 178
ALBUTEROL SULFATE 86 79 61 142
METOCLOPRAMIDE HCL 86 54 61 99
FENTANYL 85 42 S2 63 100
EVISTA 83 83 64 168
HUMULIN R 82 80 65 215
NIFEDIPINE ER 81 69 66 130
GENERLAC 80 67 67 231
CEFTRIAXONE 79 69 68 213
KLOR-CON 10 78 63 69 104
NOVOLOG MIX 70-30 77 73 70 256
SINGULAIR 77 59 70 84
AMITRIPTYLINE HCL 77 53 R 70 45
DONEPEZIL HCL 77 77 70 32
NADOLOL 75 40 74 335
POLYETHYLENE GLYCOL 3350 75 58 74 69
DIOVAN 74 56 76 67
LEVOFLOXACIN 74 43 76 73
CIPROFLOXACIN HCL 74 60 76 46
BENAZEPRIL HCL 73 28 79 61
PROMETHAZINE HCL 72 35 R 80 54
BACLOFEN 71 61 81 129
LANTUS SOLOSTAR 70 43 82 120
HUMALOG 70 53 82 192
AMLODIPINE BESYLATE-BENAZEPRIL 67 16 84 59
BUPROPION HCL SR 67 32 84 183
ENALAPRIL-HYDROCHLOROTHIAZIDE 67 35 84 247
FAMOTIDINE 66 45 87 88
SYNTHROID 65 59 88 91
FLUTICASONE PROPIONATE 64 37 89 40
ACTOS 64 60 89 119
VENTOLIN HFA 62 54 91 83
CYMBALTA 62 49 91 53
LACTULOSE 60 50 93 162
ENALAPRIL MALEATE 60 45 93 58
SPIRIVA 58 33 95 64
LUMIGAN 58 49 95 309
CRESTOR 57 43 97 30
LATANOPROST 57 57 97 222
CEFDINIR 56 42 99 122
INSULIN SYRINGE 56 51 99 93
NOVOLIN 70-30 56 56 99 160
HUMULIN 70-30 56 43 99 131
PREMARIN 55 38 R 103 109
LEVETIRACETAM 55 46 103 128
ZETIA 55 29 103 95
BISOPROLOL-HYDROCHLOROTHIAZIDE 54 22 106 101
BYSTOLIC 54 34 106 126
MECLIZINE HCL 53 50 108 80
IBUPROFEN 53 38 108 94
JANUMET 52 52 110 195
NOVOLOG 52 45 110 156
FOSINOPRIL SODIUM 51 31 112 154
LYRICA 51 18 112 47
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 31, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.